熱門資訊> 正文
iCAD任命Mark Koeniguer为CCO
2025-04-08 23:27
- iCAD (NASDAQ:ICAD) on Tuesday announced the appointment of Mark Koeniguer as chief commercial officer (CCO), to lead the next phase of global growth for iCAD.
- As CCO at iCAD, Koeniguer will assume responsibilities for revenue growth across North America and around the globe.
- In his new role, Koeniguer will have oversight of the commercial sales teams, partnerships, operations and customer success, said the company.
- Most recently, Koeniguer served as CEO of ScreenPoint Medical. He previously held executive leadership roles at Riverain Technologies, Volpara Health, R2 Technology, Stereotaxis and GE Healthcare.
- ICAD is +1.75439% to $1.74.
- Source: Press Release
More on iCAD
- ICAD targets SaaS growth with ProFound Cloud expansion and AI advancements
- Seeking Alpha’s Quant Rating on iCAD
- Historical earnings data for iCAD
- Financial information for iCAD
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
